Sepsis fluid trial pulled before it even started

NCT ID NCT07191054

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study was designed to see if a device called LifeFlow could deliver fluids faster to children with sepsis compared to the usual push-pull method. The trial planned to include 600 children but was withdrawn before any participants were enrolled. No results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

LifeFlow rapid infuser device

What this could lead to

If it had succeeded, this could have pointed toward faster, more efficient fluid delivery for children with sepsis, potentially improving outcomes.

What could go wrong

The trial was withdrawn before enrolling any participants, so no data were collected. It is unclear if the device would have proven better or safer than standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Phoenix Children's

    Phoenix, Arizona, 85016, United States